J7601
HCPCSEnsifentrine inh 3 mg
Official HCPCS Level II long descriptor
Ensifentrine, inhalation suspension, fda approved final product, non-compounded, administered through dme, unit dose form, 3 mg
HCPCS Level II code J7601 is maintained by CMS and is active in the current quarterly release.
Short descriptor
Ensifentrine inh 3 mg
Added to HCPCS: 2025-01-01
Nearby codes in J7
- J7518Mycophenolic acid
- J7519Inj. mycophenolate mofetil
- J7520Sirolimus, oral
- J7521Tacrolim granules oral susp
- J7525Tacrolimus injection
- J7527Oral everolimus
- J7528Mycophen mofetil for susp
- J7599Immunosuppressive drug noc
- J7604Acetylcysteine comp unit
- J7605Arformoterol non-comp unit
- J7606Formoterol fumarate, inh
- J7607Levalbuterol comp con
- J7608Acetylcysteine non-comp unit
- J7609Albuterol comp unit
- J7610Albuterol comp con
- J7611Albuterol non-comp con
Where this code sits
Krasyn AI Coder
Get code suggestions automatically as you type notes. Free for 50 analyses.
Install for Chrome — freeSource
HCPCS Level II July 2026 quarterly update. Centers for Medicare & Medicaid Services (CMS), “July 2026 Alpha-Numeric HCPCS File” (HCPC2026_JUL_ANWEB_06172026.txt). Download the original file from cms.gov. Public domain (US Government work). Descriptors, billable flags and instructional notes on this page are reproduced from that file without modification. Krasyn adds no clinical guidance.